CITÓMICA
Hospital de Fuenlabrada
Fuenlabrada, EspañaPublications en collaboration avec des chercheurs de Hospital de Fuenlabrada (13)
2019
-
Frequency of clonal mast cell diseases among patients presenting with anaphylaxis: A prospective study in 178 patients from 5 tertiary centers in Spain
Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, Núm. 8, pp. 2924-2926.e1
-
The poor prognosis of low hypodiploidy in adults with B-cell precursor acute lymphoblastic leukaemia is restricted to older adults and elderly patients
British Journal of Haematology, Vol. 186, Núm. 2, pp. 263-268
2016
-
Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy
Oncotarget, Vol. 7, Núm. 9, pp. 10174-10181
-
Diagnosis and classification of mastocytosis in non-specialized versus reference centres: A Spanish Network on Mastocytosis (REMA) study on 122 patients
British Journal of Haematology, Vol. 172, Núm. 1, pp. 56-63
2014
-
Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM
Journal of Allergy and Clinical Immunology, Vol. 133, Núm. 2
2013
-
Systemic mastocytosis as a risk factor for severe Hymenoptera sting-induced anaphylaxis
Journal of Allergy and Clinical Immunology
2012
-
Mast cell-related disorders presenting with Kounis syndrome
International Journal of Cardiology, Vol. 161, Núm. 1, pp. 56-58
-
Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms
International Archives of Allergy and Immunology, Vol. 157, Núm. 3, pp. 275-280
2011
-
Evaluation of basophil activation in mastocytosis with hymenoptera venom anaphylaxis
Cytometry Part B - Clinical Cytometry, Vol. 80 B, Núm. 3, pp. 167-175
-
Evaluation of the WHO criteria for the classification of patients with mastocytosis
Modern Pathology, Vol. 24, Núm. 9, pp. 1157-1168
-
Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis
Immunotherapy, Vol. 3, Núm. 5, pp. 637-651
2010
-
Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms
Journal of Allergy and Clinical Immunology, Vol. 125, Núm. 6
2008
-
Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis
Journal of Allergy and Clinical Immunology, Vol. 121, Núm. 2, pp. 519-526